April 2023
-
Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye
IASLC Pathology Committee members say the identification and evaluation of features that result in discordance in measuring invasive tumor size will hopefully improve reproducibility and lead to more accurate tumor staging moving forward.
-
Primary AEGEAN Analysis Shows Improved EFS, pCR with Periadjuvant Durvalumab
Investigator Dr. John Heymach says the positive phase 3 data may lead to a potential new treatment option for patients with resectable NSCLC.
-
Investigator Shares Findings That Point to Possible Mechanism of SCLC Plasticity
During IASLC’s 2023 Hot Topic Meeting on small cell lung cancer, Dr. Trudy Oliver discussed how MYC genes drive the evolution of SCLC subtypes.
-
Closing Keynote Highlights Progress, Challenges in Management of SCLC
From new diagnostic approaches to new evidence on the potential mechanisms of treatment resistance, Dr. Charles M. Rudin looked back on how small cell research has evolved and what needs remain.
-
In Brief for April 26, 2023
US Food and Drug Administration grants Fast Track designation for novel mesothelioma therapy.
-
IASLC Staging Project Finalizing Recommendations for 9th Edition of TNM Classification System
In a recent interview, Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura provides an update on efforts to further refine the system.
-
Staging Experts Offer Insights on Challenges of Nodal Classification
Adding to the discussion, Drs. David Ball, Daniel Steinfort, and Susan Harden propose alternative approaches for the complex task of improving nodal staging.
-
Mesothelioma Pioneer Delivers 2023 Heine H. Hansen Keynote Lecture
The Netherlands Cancer Institute’s Dr. Paul Baas was honored for his significant contributions to lung cancer research during the 2023 European Lung Cancer Congress.
-
Thoracic Oncologists Divided Regarding Role of Neoadjuvant Chemoimmunotherapy
Consensus eluded 2023 European Lung Cancer Congress attendees during a debate on the best approach for NSCLC.
-
From the Editors April 12, 2023
ILCN Associate Editors Drs. Suresh Senan and Witold Rzyman add clinical perspective to surveillance frequency discussion.
View ILCN Archives
Provider Resources